Robert Hershberg

Director, Recursion Pharmaceuticals, Inc.; Director, Adaptive Biotechnologies Corp

Bought, 12 months

$0.0M

Sold, 12 months

$1.2M

Companies

Latest trade

Oct 6, 2026

Companies

Recursion Pharmaceuticals, Inc.Director −$0.1M Adaptive Biotechnologies CorpDirector −$1.1M

Trades

RXRX Sold 25,000 shares at $5.00 · planned $0.1M Oct 6

ADPT Sold 30,664 shares at $24.40 $0.7M Aug 18

ADPT Sold 22,968 shares at $16.00 $0.4M Dec 10

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.